South Korean scientists may restore vision with new drug

Scientists have developed a drug that regenerates damaged eye tissue, potentially restoring vision for millions. This breakthrough targets the root cause of vision loss, not just its symptoms. The experimental drug, developed in South Korea, works by blocking the Prox1 protein, which inhibits the retina's ability to repair itself. Initial tests on mice showed sustained restoration of visual function. Human clinical trials are scheduled to begin in 2028, offering hope for those with age-related macular degeneration, diabetic retinopathy, and other conditions causing vision loss.